Psilocybin prevents chemotherapy-induced neuropathic pain through a 5-HT2A receptor-dependent mechanism

Cited in blog · Science Translational Medicine. · 2024

Zhou, Y., et al. (2024). *Psilocybin prevents chemotherapy-induced neuropathic pain through a 5-HT2A receptor-dependent mechanism*. Science Translational Medicine.

Authors

Zhou, Y., et al.

Research lens

Zhou, Y., et al. (2024). *Psilocybin prevents chemotherapy-induced neuropathic pain through a 5-HT2A receptor-dependent mechanism*. Science Translational Medicine.

  • blog
  • psilocybin-chemo-nerve-damage-2026-10-02